Savant Capital LLC Decreases Stock Position in Tenet Healthcare Corporation $THC

Savant Capital LLC cut its stake in Tenet Healthcare Corporation (NYSE:THC) by 77.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,846 shares of the company’s stock after selling 13,048 shares during the quarter. Savant Capital LLC’s holdings in Tenet Healthcare were worth $764,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. WCM Investment Management LLC grew its position in shares of Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after purchasing an additional 362,083 shares in the last quarter. Caption Management LLC purchased a new position in shares of Tenet Healthcare in the third quarter valued at $5,650,000. Eminence Capital LP purchased a new position in shares of Tenet Healthcare in the third quarter valued at $225,263,000. Hillsdale Investment Management Inc. grew its position in shares of Tenet Healthcare by 31.0% in the third quarter. Hillsdale Investment Management Inc. now owns 22,800 shares of the company’s stock valued at $4,629,000 after purchasing an additional 5,400 shares in the last quarter. Finally, GenTrust LLC purchased a new position in shares of Tenet Healthcare in the third quarter valued at $895,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Nadja West sold 3,000 shares of the business’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 23,138 shares of company stock worth $4,976,589. Insiders own 0.97% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on THC shares. Guggenheim dropped their price objective on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a research note on Friday, May 1st. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Wells Fargo & Company dropped their price objective on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Finally, Royal Bank Of Canada dropped their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Trading Down 3.4%

Shares of THC stock opened at $164.28 on Wednesday. Tenet Healthcare Corporation has a 12-month low of $146.60 and a 12-month high of $247.21. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The business has a 50-day moving average price of $189.23 and a two-hundred day moving average price of $201.72. The firm has a market cap of $14.15 billion, a P/E ratio of 8.54, a price-to-earnings-growth ratio of 1.12 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the previous year, the company posted $4.36 EPS. Tenet Healthcare’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.